Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3233/JND-200520 http://scihub22266oqcxt.onion/10.3233/JND-200520 32508329!7369032!32508329     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Neuromuscul+Dis 2020 ; 7 (3): 361-364 Nephropedia Template TP {{tp|p=32508329|t=2020. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome |pdf=|usr=}}{{32508329}} gab.com Text COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome JO: J Neuromuscul Dis http://www.kidney.de/pget.php?&tw=1&pmid=32508329 #FOAvip This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient. Twit Text FOAVip COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome ????J Neuromuscul Dis http://www.kidney.de/pget.php?&tw=1&pmid=32508329 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32508329 #FOAvip English Wikipedia <ref>{{Cite pmid|32508329}}</ref> COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome #MMPMID32508329 Ramaswamy SB; Govindarajan R J Neuromuscul Dis 2020[]; 7 (3): 361-364 PMID32508329show ga This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient. |*Betacoronavirus[MESH] |Adult[MESH] |COVID-19[MESH] |Chronic Disease[MESH] |Coronavirus Infections/*complications[MESH] |Female[MESH] |Humans[MESH] |Immunosuppressive Agents/*therapeutic use[MESH] |Myasthenia Gravis/complications/*drug therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications[MESH] |Precision Medicine/methods[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful (epmc).pdf DeepDyve Pubget Overpricing